All Articles

A state-backed project revisits the Long March's pivotal moments in Gansu, framing revolutionary history as a tool for modern national rejuvenation and global soft power.

Atrium Therapeutics' clinical trial for a rare cardiomyopathy isn't just a milestone; it's a strategic maneuver signaling the arrival of precision RNA therapies in cardiology.

The payment giant says operations are normal and refuses to pay hackers. But with business data and transaction records stolen, what is the true cost of defiance?

SCRYPT's new stablecoin corridors in East Africa bypass dollar scarcity, positioning digital assets as vital infrastructure, not speculative bets.

As new FRS 102 rules overhaul UK lease accounting, Crunchafi's software launch signals a high-stakes battle for a market where spreadsheets no longer suffice.

Telana renews its exclusive Microsoft Azure Expert MSP status, validating its model for freeing UK firms from operational toil to drive tangible, AI-led growth.

For 18 years, WEI has dominated a key industry ranking. This isn't luck; it's a masterclass in strategic execution. Here's how they do it.

A national home improvement firm is ditching legacy data silos for a modern AI-ready foundation. It’s a move that reveals the real work behind AI's promise.

A new B2BINPAY update focuses on operational stability, not hype. These tedious but vital changes signal the maturation of crypto from asset to utility.

Elevara Medicines taps biotech veteran Dr. Mai-Britt Zocca to lead its charge against rheumatoid arthritis with a novel drug and $70M in backing.

A new watchdog emerges as millions use unapproved GLP-1 drugs, many believing they're FDA-approved. How a shortage solution became a risky shadow market.

With a new suite of scalable edge solutions, Infortrend targets the diverse needs of enterprises, aiming to simplify AI deployment beyond the traditional data center.

RWS launches an integrated linguistic validation service, using AI and a single-vendor model to tackle the costly delays plaguing global clinical trials.

Eluviant, formerly IntelexVision, launches its Aurora Flow AI to understand human motion. But as surveillance gets smarter, what are the costs?

With ASTM approval secured and mandates looming, Argus Media's new methanol-to-jet index provides the pricing transparency needed to fuel aviation's costly green transition.

As UK demand for global cuisine soars, JK Foods expands its frozen range, betting that authenticity and convenience can transform both kitchens and supply chains.

After a slow start, Canada's housing market is stirring. Pent-up demand meets economic caution, creating a complex picture of regional divides.

GAM's activist managers up their stake in Liontrust and target Impax, citing deep undervaluation and exposing fractures in a UK fund sector under pressure.

As Velo sponsors Tomorrowland, we uncover a strategy to embed nicotine in youth culture, testing festival ethics and looming regulatory crackdowns.

A surge in demand for Lamborghinis isn't just a lifestyle trend. It's a high-octane signal of Dubai's roaring economic success and strategic positioning.